期刊文献+

加替沙星-聚癸二酸酐局部缓释系统的生物相容性 被引量:2

Biocompatibility of gatifloxacin-poly(sebacic anhydride) local control release system
下载PDF
导出
摘要 背景:聚酸酐材料具有表面溶蚀性、生物可降解性和释药速率可调性,已被美国食品和药物管理局批准用于人体药物缓释材料。目的:研究加替沙星-聚癸二酸酐局部缓释系统的制备及生物相容性。方法:采用熔融缩聚的方法制备聚癸二酸酐,将加替沙星与聚癸二酸酐充分混合,制成载药量20%的加替沙星-聚癸二酸酐局部缓释药棒。切开6只新西兰大耳白兔背部皮肤,随机分组:实验组在脊柱两旁椎旁肌肌袋内植入聚癸二酸酐棒,对照组未植入任何材料。术后第5周取材,观察皮下组织和肌肉组织变化,以及心、肝、肾及肺的变化。结果与结论:聚癸二酸酐生物相容性良好,植入期间兔未出现任何食欲和行为改变,植入部位未见明显红肿、出血及糜烂,植入材料表面呈多孔状,表明材料在皮下已发生降解吸收,但未发生脆裂和崩解,与周围组织形成轻微粘连;兔肝、肾、肺、心组织结构未发生改变。表明加替沙星-聚癸二酸酐局部缓释制剂无毒、无致畸作用,组织相容性好。 BACKGROUND: Polyanhydride material is characteristics of surface erosion, biodegradability and release rate adjustability, and it has been approved by the U.S. Food and Drug Administration for human drug carrier materials. OBJECTIVE: To prepare gatifloxa-poly(sebacic anhydride) local control release system and study its biocompatibility. METHODS: Poly(sebacic anhydride) was prepared with melt phase polycondensation method, and mixed with gatifloxacin in the agate mortar to make a local drug delivery system at 20% drug loading. Six rabbits were used to study the biocompatibility of poly(sebacic anhydride) and their back skin was cut open. Six rabbits were randomly divided into two groups, the experimental group was implanted with poly(sebacic anhydride) stick into the paraspinal muscle pouch, while the control group received no implants. Rabbits were killed at 5 weeks post-surgery, and changes on subcutaneous tissue and muscle tissue were observed, as well heart, liver, kidney and lung. RESULTS AND CONCLUSION: Poly(sebacic anhydride) has a good biocompatibility. After implantation, no rabbit appeared to have the change of appetite and behavior. There was no edema, hemorrhage and erosion at the implanted site, and the surface of implanted materials was porous, which suggested that the materials had been degraded and absorbed subcutaneously. In addition, embrittlement and disintegration were not observed; the implanted materials slightly adhered to surrounding tissue. There was no change in the liver, kidney, lung, heart and partial musculature. Gatifloxacin-poly(sebacic anhydride) local sustained release preparation is well histocompatible with no toxicity and teratogenic action.
出处 《中国组织工程研究》 CAS CSCD 2013年第25期4623-4628,共6页 Chinese Journal of Tissue Engineering Research
关键词 生物材料 材料生物相容性 聚癸二酸酐 聚酸酐 加替沙星-聚癸二酸酐缓释制剂 生物相容性 生物降解 药物缓释材料 biomaterials material biocompatibility poly(sebacic anhydride) polyanhydride gatifloxacin-poly(sebacic anhydride) sustained release preparations biocompatibility biodegradation drugdelivery materials
  • 相关文献

参考文献12

二级参考文献76

  • 1副岛林造.Gatifloxacin(GFLX)の概要[J].日本化学疗法学会杂志,1999,47(2):1-1.
  • 2Perry CM,Ormrod D, Hurst M, et al. Gatifloxacin: a review of its use in the management of bacterial infections[J]. Drugs,2002,62 : 169.
  • 3Cox CE, Marbury TC, Pittman WG, et al. A randomized,doubleblind , multicenter comparison of gatifloxacin versus cipyofloxacin in the treatment of complicated urinary tract infection and pyelonephritis [J]. Clin Ther,2002,24 : 223.
  • 4Gotfried MH ,DeAbate CA,Fogayty C, et al. Comparison of 5d,short-eourse gatifloxacin therapy with 7d gatifloxacin therapy and 10d clarithromycin therapy for acute exacerbation of chronic bronchitis[J]. Clin Ther, 2001,23:97.
  • 5Sher LD,McAdco MA, Bettis RB, et al. A multicenter,randomized,investigator-blinded study of 5d and 10d gatifloxacin versus 10d amoxicillin/clavulanate in patients with acute bacterial sinusitis[J]. Clin Ther,2002,24:269.
  • 6柴孝也.健康成人におけゐgatifloxacinの体内动态に及ほす水酸化ろルミニウム及びシメジンの影响[J].日本化学疗法学会杂志,1999,47(S-2):218.
  • 7柴孝也.健康成人におけゐgatifloxacinの体内动态に及ぼす铁剂の并用,びに绿茶またば牛乳によゐ服药の影响[J].日本化学疗法学会杂志,1999,47(S-2):224.
  • 8(文)藤笃,中山一朗,大道光秀,他.内科领域感染症に对すゐgatifloxacin の前期第Ⅱ相临床试验[J].日本化学疗法学会杂志,1999,47(S-2):260.
  • 9(文)藤笃,大道光秀,荒川正昭,他.呼吸器感染症に对すゐgatifloxacinの后期第Ⅱ相临床试验[J].日本化学疗法学会杂志,1999,47(S-2):277.
  • 10河田幸道,熊本悦明,折笠精一,他.泌尿器科领域感染症に对すゐgatifloxacinの前期第Ⅱ相临床试验[J].日本化学疗法学会杂志,1999,47(S-2):292.

共引文献163

同被引文献28

  • 1李绪春,朱红.单剂量加替沙星口服在Beagle犬体内药代动力学研究[J].中国药业,2006,15(10):6-7. 被引量:4
  • 2吴瀛达,戚双双.加替沙星不良反应23例分析[J].中国药物与临床,2006,6(10):799-800. 被引量:12
  • 3杨秀芬,曾繁典,周志彬,黄开勋,徐辉碧.聚(油酸/亚油酸-癸二酸)-庆大霉素在家兔体内的释药实验及相容性研究[J].中国新药杂志,2007,16(16):1265-1268. 被引量:1
  • 4Domb AJ,Rock M,Perkin C.Excretion of a radiolabeledanticancer biodegradable polymeric implant from the rabbitbrain.Biomaterials.1995;16(14):1069-1072.
  • 5Norden CW,Shafferm M.Experimental osteomyelitis due toStaphylococcus aureus or Pseudomonas aeruginosa:aradiographic-pathological correlative analysis.Br J Exp Pathol.1980;61(4):451-460.
  • 6Laurence ED,Charle H.Gentamicin-loaded plaster of Parisas a treatment of experimental osteomyelitis in rabbits.ClinOrthop Relat Res.1987:(219):278-282.
  • 7Ostermann PA,Seiigson D,Henry SL.Local antibiotic therapyfor severe open fractures.A review of 1085 consecutivecases.J Bone Joint Surg Br.1995:77(1):93-97.
  • 8Grace EJ,Bryoson V.Modern treatment of chronicosteomyelitis with topical detergent antibiotic therapy.SurgGynecol Obstet.1950;91(3):333-342.
  • 9Perry CR,Kitterbusch JK,Rice SH,et al.Antibiotics deliveredby an implantable drug pump;a new application for treatingosteomyelitis.Am J Med.1986;80(6B):222-227.
  • 10Kahn DS,Pritzker KP.The pathophysiology of bone infection.Clin Orthop Relat Res.1973;8(96):12-19.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部